Citation only
via OpenAlex
Intravitreal Bevacizumab (Avastin) for Neovascular Age-Related Macular Degeneration
Robert L. Avery, Dante J. Pieramici, Melvin Rabena, ALESSANDRO A. CASTELLARIN, Ma'an A. Nasir, Matthew J. Giust
Ophthalmology · 2006 · ▲ 1,133 citations
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1016/j.ophtha.2005.11.019
- Canonical
- link ↗
- Fetched
- 2026-10-19 MST
Cite this
APA
Avery, R.L., Pieramici, D.J., Rabena, M., CASTELLARIN, A.A., Nasir, M.A., & Giust, M.J. (2006). Intravitreal Bevacizumab (Avastin) for Neovascular Age-Related Macular Degeneration. <em>Ophthalmology</em>. https://doi.org/10.1016/j.ophtha.2005.11.019
Vancouver
Avery RL, Pieramici DJ, Rabena M, CASTELLARIN AA, Nasir MA, Giust MJ. Intravitreal Bevacizumab (Avastin) for Neovascular Age-Related Macular Degeneration. Ophthalmology. 2006. doi:10.1016/j.ophtha.2005.11.019.
BibTeX
@article{robert2006Intrav,
title = {Intravitreal Bevacizumab (Avastin) for Neovascular Age-Related Macular Degeneration},
author = {Robert L. Avery and Dante J. Pieramici and Melvin Rabena and ALESSANDRO A. CASTELLARIN and Ma'an A. Nasir and Matthew J. Giust},
journal = {Ophthalmology},
year = {2006},
doi = {10.1016/j.ophtha.2005.11.019},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Drugs 2008
Citation only
Neovascular Age-Related Macular Degeneration
Ophthalmology 2012
Preprint · OA
Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration
Ophthalmology 2013
Citation only
Intravitreal Aflibercept Injection for Neovascular Age-related Macular Degeneration
American Journal of Ophthalmology 2006
Citation only
Intravitreal Bevacizumab for the Management of Choroidal Neovascularization in Age-related Macular Degeneration
Instituto de Olhos de Goiania 2005
Open access · US-GOV
Intravitreal Bevacizumab for Choridal Neovascularization Secondary to Age-Related Macular Degeneration
Drugs & Aging 2002
Citation only